The topic Subtype 1 Rosacea you are seeking is a synonym, or alternative name, or is closely related to the medical condition Erythematotelangiectatic Rosacea.

Quick Summary:

• Rosacea is a common, benign, and chronic skin disorder that manifests as reddish skin with papules and pustules on the face, especially near the eyes, nose, and mouth. It occurs due to inflammation of the pilosebaceous glands and sweat glands
• Erythematotelangiectatic Rosacea is a subtype of Rosacea. There are 4 subtypes of rosacea:
  • Subtype 1 Erythematotelangiectatic Rosacea
  • Subtype 2 Papulopustular Rosacea
  • Subtype 3 Phymatous Rosacea
  • Subtype 4 Ocular Rosacea
• Rosacea is more common in women (75% of the cases are observed in them). The onset of Erythematotelangiectatic Rosacea may occur during young adulthood; a peak incidence is seen during middle-age
• The cause is generally unknown, but it may be linked to  the presence of acne during adolescence. The condition can also be aggravated by a variety of factors, most importantly by alcohol consumption
• Erythematotelangiectatic Rosacea causes facial redness and flushing. It can lead to dry and thickened skin. Since, it is a longstanding condition with exacerbation and remission of symptoms over a long period, it can result in severe emotional stress and trauma in some individuals
• Currently, no treatment measures are available for Erythematotelangiectatic Rosacea that can ensure its cure. However, a lack of treatment can make the condition much worse. A symptomatic management of the condition and avoidance of the aggravating factors is generally practiced
• The prognosis for Erythematotelangiectatic Rosacea is good with suitable treatment; however, the skin condition can recur. In some, the condition may be difficult to treat, since it may not respond to treatment

Please find comprehensive information on Erythematotelangiectatic Rosacea regarding definition, distribution, risk factors, causes, signs & symptoms, diagnosis, complications, treatment, prevention, prognosis, and additional useful information HERE.